ClinConnect ClinConnect Logo
Search / Trial NCT06504979

The Post Intensive Care Syndrome Follow-up and Management Study: the ICU Recovery Answers Project

Launched by CORPORACION PARC TAULI · Jul 10, 2024

Trial Information

Current as of July 09, 2025

Enrolling by invitation

Keywords

Post Intensive Care Syndrome Icu Survivors Icu Families Cognition Emotional State

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult (≥18 years old) critically ill patients admitted to the ICU with or without need of invasive mechanical ventilation (IMV).
  • Exclusion Criteria:
  • Non-authorization of the relatives and/or patient to inclusion in the study; neurocritical ICU patients.
  • Severe neurological pathology (including dementia or focal brain damage with functional and cognitive impairment) prior to admission to the ICU.
  • Severe psychiatric pathology (schizophrenia, bipolar disorder, major depressive disorder)
  • Intellectual disability (IQ \<80).
  • Patients who develop secondary complications (infections, stroke, TBI or any non-transient acquired brain damage) after ICU discharge, that may compromise the results of the emotional and neuropsychological evaluation during the recovery phase
  • Moderate-severe cognitive impairment (Short-IQCODE \>85) that impair ICU patients an independent participation in the telematic follow up and accompaniment program
  • Readmission to ICU within 12 months after discharge from ICU
  • Idiomatic barrier (non spanish and/or catalan speaker)
  • Patients with life expectancy \<1 year or not subsidiaries of active treatment measures.

About Corporacion Parc Tauli

Corporación Parc Taulí is a leading healthcare organization based in Sabadell, Spain, known for its commitment to advancing medical research and clinical excellence. With a focus on innovative healthcare solutions, the organization integrates cutting-edge technology and multidisciplinary collaboration to enhance patient outcomes. As a sponsor of clinical trials, Corporación Parc Taulí emphasizes ethical practices, rigorous scientific methodologies, and robust data management to contribute to the development of new therapies and improve healthcare standards. Their dedication to research and patient care positions them as a vital player in the clinical research landscape.

Locations

Sabadell, Barcelona, Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported